To evaluate the association between C-reactive protein (CRP) and 10-year risk of cardiovascular (CV) events using the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis (ERS-RA), based on conventional and RA-specific risk factors but not CRP, in RA patients without previous cardiovascular events.
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis / Erre, G.L., Cacciapaglia, F., Sakellariou, G., Manfredi, A., Bartoloni, E., Viapiana, O., Fornaro, M., Cauli, A., Mangoni, A.A., Woodman, R.J., Palermo, B.L., Gremese, E., Cafaro, G., Nucera, V., Vacchi, C., Spinelli, F.R., Atzeni, F., Piga, M.. - In: EUROPEAN JOURNAL OF INTERNAL MEDICINE. - ISSN 1879-0828. - (2022). [10.1016/j.ejim.2022.07.001]
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis
Erre, Gian Luca
Writing – Original Draft Preparation
;Mangoni, Arduino Aleksander;
2022-01-01
Abstract
To evaluate the association between C-reactive protein (CRP) and 10-year risk of cardiovascular (CV) events using the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis (ERS-RA), based on conventional and RA-specific risk factors but not CRP, in RA patients without previous cardiovascular events.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
